ArticleBMC infectious diseases2026
Audit of antibiotic prescribing practices for pediatric pneumonia in the outpatient department: focus on amoxicillin and azithromycin.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntibiotic overuse in childhood pneumonia contributes significantly to antimicrobial resistance, particularly in low- and middle-income countries (LMICs). This clinical audit evaluated outpatient antibiotic prescribing practices, implemented targeted educational interventions, and assessed improvements in the appropriateness of prescribing.
methodsA two-cycle clinical audit was conducted at the Children Hospital, Sukkur (SICHN), Pakistan. Children under 15 years diagnosed with pneumonia by treating clinicians in the outpatient department were included during pre-audit (n = 132) and post-audit (n = 153) phases. The audit focused on patients who received antibiotics, evaluating appropriateness in terms of choice, dose, and duration according to WHO AWaRe and IMNCI guidance. Educational sessions and real-time feedback were provided between audit cycles. Data on demographics, clinical features, antibiotic prescriptions, and follow-up were analyzed.
resultsOverall antibiotic prescribing remained high (116/132 [87.9%] pre-audit vs. 135/153 [88.2%] post-audit). However, prescribing quality improved substantially. Amoxicillin use increased from 26/132 (19.7%) to 119/153 (77.8%), with appropriate prescribing rising from 1/26 (3.8%) to 96/119 (80.7%). Azithromycin use decreased from 66/132 (50.0%) to 5/153 (3.3%), with appropriate use improving from 20/66 (30.3%) to 4/5 (80.0%). Documentation practices improved, although objective diagnostic criteria were inconsistently recorded. Follow-up rates remained low (~ 15%), but most returning patients showed clinical improvement.
conclusionStructured audit and feedback significantly improved the appropriateness of antibiotic prescribing for children diagnosed with pneumonia in outpatient settings. While overall prescribing rates remained unchanged, a marked shift toward guideline-recommended antibiotic use highlights the effectiveness of stewardship-focused interventions in resource-limited, real-world clinical environments. CLINICAL
trial registrationThis study was a clinical audit and not an interventional clinical trial. CLINICAL TRIAL NUMBER: not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.